亚托皮性皮肤炎的诊断标准

The Eczema Area and Severity Index: An update of progress and challenges in its measurement of atopic dermatitis after 20 years of use.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024

Implementation of the HOME core outcome set for clinical trials of atopic eczema-barriers and opportunities: the HOME IX meeting report.

Archives of dermatological research·2023

Can atopic eczema and psoriasis coexist? A systematic review and meta-analysis.

Skin health and disease·2022

Artificial intelligence and machine learning algorithms for early detection of skin cancer in community and primary care settings: a systematic review.

The Lancet. Digital health·2022

Eczema Care Online: development and qualitative optimisation of an online behavioural intervention to support self-management in young people with eczema.

BMJ open·2022

Avoidable research waste in dermatology: what are the solutions?

The British journal of dermatology·2022

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Postpartum-onset anti-PM/Scl-positive dermatomyositis-systemic sclerosis overlap syndrome with reversible interstitial lung disease: a case report.

Frontiers in medicine·2026

Severe recurrent anaphylaxis: investigating underlying mechanisms beyond IgE-mediated allergy - a case report.

Frontiers in allergy·2026

Upadacitinib for refractory generalized lichen sclerosus: a case report and brief literature review.

Frontiers in immunology·2026

Case Report: A case report of bullous pemphigoid triggered by sintilimab (PD-1 inhibitor).

Frontiers in immunology·2026

Efficacy and safety of dupilumab following discontinuation of JAK inhibitors in patients with moderate-to-severe atopic dermatitis: a single-center retrospective study.

Frontiers in immunology·2026

Successful management of pembrolizumab-associated Stevens-Johnson syndrome/toxic epidermal necrolysis in a patient with uterine serous carcinoma: a case report.

Frontiers in immunology·2026

相关实验视频

亚托皮性皮肤炎的诊断标准

相关概念视频

The Eczema Area and Severity Index: An update of progress and challenges in its measurement of atopic dermatitis after 20 years of use.

Implementation of the HOME core outcome set for clinical trials of atopic eczema-barriers and opportunities: the HOME IX meeting report.

Can atopic eczema and psoriasis coexist? A systematic review and meta-analysis.

Artificial intelligence and machine learning algorithms for early detection of skin cancer in community and primary care settings: a systematic review.

Eczema Care Online: development and qualitative optimisation of an online behavioural intervention to support self-management in young people with eczema.

Avoidable research waste in dermatology: what are the solutions?

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Postpartum-onset anti-PM/Scl-positive dermatomyositis-systemic sclerosis overlap syndrome with reversible interstitial lung disease: a case report.

Severe recurrent anaphylaxis: investigating underlying mechanisms beyond IgE-mediated allergy - a case report.

Upadacitinib for refractory generalized lichen sclerosus: a case report and brief literature review.

Case Report: A case report of bullous pemphigoid triggered by sintilimab (PD-1 inhibitor).

Efficacy and safety of dupilumab following discontinuation of JAK inhibitors in patients with moderate-to-severe atopic dermatitis: a single-center retrospective study.

Successful management of pembrolizumab-associated Stevens-Johnson syndrome/toxic epidermal necrolysis in a patient with uterine serous carcinoma: a case report.

相关实验视频

亚托皮性皮肤炎的诊断标准

相关概念视频

相关文章